These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
142 related items for PubMed ID: 27859746
1. A Prospective, Randomized, Masked, Placebo-Controlled Clinical Study of Capromorelin in Dogs with Reduced Appetite. Zollers B, Wofford JA, Heinen E, Huebner M, Rhodes L. J Vet Intern Med; 2016 Nov; 30(6):1851-1857. PubMed ID: 27859746 [Abstract] [Full Text] [Related]
2. Capromorelin oral solution (ENTYCE®) increases food consumption and body weight when administered for 4 consecutive days to healthy adult Beagle dogs in a randomized, masked, placebo controlled study. Zollers B, Rhodes L, Heinen E. BMC Vet Res; 2017 Jan 05; 13(1):10. PubMed ID: 28056951 [Abstract] [Full Text] [Related]
3. Evaluation of the safety in dogs of long-term, daily oral administration of capromorelin, a novel drug for stimulation of appetite. Zollers B, Huebner M, Armintrout G, Rausch-Derra LC, Rhodes L. J Vet Pharmacol Ther; 2017 Jun 05; 40(3):248-255. PubMed ID: 27665742 [Abstract] [Full Text] [Related]
4. Evaluating the Safety and Efficacy of Capromorelin in Rhesus Macaques (Macaca mulatta). Campellone GA, Easley KA, Jenkins JB, Jean SM. J Am Assoc Lab Anim Sci; 2024 May 01; 63(3):268-278. PubMed ID: 38423529 [Abstract] [Full Text] [Related]
5. Evaluation of the safety of daily administration of capromorelin in cats. Wofford JA, Zollers B, Rhodes L, Bell M, Heinen E. J Vet Pharmacol Ther; 2018 Apr 01; 41(2):324-333. PubMed ID: 29057482 [Abstract] [Full Text] [Related]
6. Insights on discovery, efficacy, safety and clinical applications of ghrelin receptor agonist capromorelin in veterinary medicine. Rathore M, Das N, Ghosh N, Guha R. Vet Res Commun; 2024 Feb 01; 48(1):1-10. PubMed ID: 37493940 [Abstract] [Full Text] [Related]
7. Capromorelin increases food consumption, body weight, growth hormone, and sustained insulin-like growth factor 1 concentrations when administered to healthy adult Beagle dogs. Zollers B, Rhodes L, Smith RG. J Vet Pharmacol Ther; 2017 Apr 01; 40(2):140-147. PubMed ID: 27597271 [Abstract] [Full Text] [Related]
8. Capromorelin, a ghrelin receptor agonist, increases feed intake and body weight gain in broiler chickens (Gallus gallus domesticus). Ceron-Romero N, Taofeek N, Thomas A, Vroonland E, Sanmartin K, Verghese M, Heinen E, Vizcarra JA. Poult Sci; 2021 Aug 01; 100(8):101204. PubMed ID: 34182219 [Abstract] [Full Text] [Related]
9. The effect of capromorelin on glycemic control in healthy dogs. Pascutti KM, O'Kell AL, Hill RC, Castro RA, Salute ME, Gilor C. Domest Anim Endocrinol; 2022 Oct 01; 81():106732. PubMed ID: 35689953 [Abstract] [Full Text] [Related]
10. Comparison of Effects of Capromorelin and Mirtazapine on Appetite in New Zealand White Rabbits (Oryctolagus cuniculus). Draper JM, Savson DJ, Lavin ES, Feldman ER, Singh B, Martin-Flores M, Daugherity EK. J Am Assoc Lab Anim Sci; 2022 Sep 01; 61(5):495-505. PubMed ID: 35981857 [Abstract] [Full Text] [Related]
11. Detection of capromorelin in urine following oral and dermal routes of administration. Sobolevsky T, Walpurgis K, Goergens C, Fedoruk M, Lewis L, Ahrens B, Thevis M. Drug Test Anal; 2023 Sep 01; 15(11-12):1449-1453. PubMed ID: 37688359 [Abstract] [Full Text] [Related]
12. Capromorelin: a ghrelin receptor agonist and novel therapy for stimulation of appetite in dogs. Rhodes L, Zollers B, Wofford JA, Heinen E. Vet Med Sci; 2018 Feb 01; 4(1):3-16. PubMed ID: 29468076 [Abstract] [Full Text] [Related]
13. The effect of the ghrelin-receptor agonist capromorelin on glucose metabolism in healthy cats. Pires J, Greathouse RL, Quach N, Huising MO, Crakes KR, Miller M, Gilor C. Domest Anim Endocrinol; 2021 Jan 01; 74():106484. PubMed ID: 32619812 [Abstract] [Full Text] [Related]
14. A ghrelin receptor agonist is an effective colokinetic in rats with diet-induced constipation. Pustovit RV, Furness JB, Rivera LR. Neurogastroenterol Motil; 2015 May 01; 27(5):610-7. PubMed ID: 25616061 [Abstract] [Full Text] [Related]
16. A Prospective, Randomized, Masked, Placebo-Controlled Multisite Clinical Study of Grapiprant, an EP4 Prostaglandin Receptor Antagonist (PRA), in Dogs with Osteoarthritis. Rausch-Derra L, Huebner M, Wofford J, Rhodes L. J Vet Intern Med; 2016 May 01; 30(3):756-63. PubMed ID: 27075237 [Abstract] [Full Text] [Related]